OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 62 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,462 | -50.9% | 13,322 | 0.0% | 0.00% | – |
Q1 2023 | $15,187 | +1.8% | 13,322 | 0.0% | 0.00% | – |
Q4 2022 | $14,921 | -46.7% | 13,322 | 0.0% | 0.00% | – |
Q3 2022 | $28,000 | -37.8% | 13,322 | -59.3% | 0.00% | – |
Q2 2022 | $45,000 | -19.6% | 32,713 | 0.0% | 0.00% | – |
Q1 2022 | $56,000 | -70.1% | 32,713 | -47.2% | 0.00% | – |
Q2 2021 | $187,000 | -33.2% | 61,991 | -27.8% | 0.00% | – |
Q1 2021 | $280,000 | -17.6% | 85,861 | +4.1% | 0.00% | – |
Q4 2020 | $340,000 | -33.9% | 82,512 | -13.1% | 0.00% | – |
Q3 2020 | $514,000 | -16.4% | 94,977 | +4.0% | 0.00% | – |
Q2 2020 | $615,000 | +195.7% | 91,333 | +40.2% | 0.00% | – |
Q1 2020 | $208,000 | -22.7% | 65,152 | +69.8% | 0.00% | – |
Q4 2019 | $269,000 | +69.2% | 38,374 | -6.8% | 0.00% | – |
Q3 2019 | $159,000 | +6.7% | 41,162 | +5.3% | 0.00% | – |
Q2 2019 | $149,000 | +6.4% | 39,098 | +1.0% | 0.00% | – |
Q1 2019 | $140,000 | -52.7% | 38,706 | +1.7% | 0.00% | – |
Q4 2018 | $296,000 | – | 38,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,148,832 | $8,801,000 | 3.14% |
Rovida Advisors Inc. | 3,000,000 | $3,210,000 | 0.14% |
Zebra Capital Management LLC | 24,384 | $26,000 | 0.04% |
TITLEIST CAPITAL, LLC | 80,184 | $87,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,125,689 | $1,216,000 | 0.01% |
ArrowMark Colorado Holdings LLC | 1,000,000 | $1,080,000 | 0.01% |
Insight Advisors, LLC/ PA | 24,800 | $27,000 | 0.01% |
Renaissance Technologies | 1,355,774 | $1,464,000 | 0.00% |
Engineers Gate Manager LP | 42,810 | $46,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 249,851 | $270,000 | 0.00% |